Aprameya Engineering Limited
Bookbuilding IPO · NSE
- Price band
- ₹56 - ₹58
- Lot size
- 2,000 shares
- Issue amount
- ₹29.23 cr
- Total subscription
- 181×
- Opens
- 25 Jul 2024
- Closes
- 29 Jul 2024
- Allotment
- 30 Jul 2024
- Listing
- 1 Aug 2024
Offer at a glance
Issue overview
- Issue size
- 50,40,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,12,000
- Fresh issue
- ₹29.23 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,16,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,40,00,000
- Shares after issue
- 1,90,40,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 2,000 | ₹1,16,000 |
| HNI | 2 | 4,000 | ₹2,32,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 5.56 | 501.69 |
| RETAIL | 9.72 | 1,617.81 |
| NIB | 4.16 | 1,399.35 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 2.47 | 11.87 | 0.73 |
| ROE | 15.97 | 182.04 | 28.97 |
| ROCE | 9.6 | 88.78 | 46.31 |
| RONW | 14.79 | 114.38 | 27.36 |
| PRE IPO(PE) | 15.12 | 0 | 0 |
| POST IPO(PE) | 20.57 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Aprameya Engineering Limited, founded in September 2003, specializes in setting up and maintaining hospital facilities like ICUs, NICUs, PICUs, Operation Theatres, and prefab structure wards on a turnkey basis. The company also supplies high-quality medical and diagnostic equipment to private and government hospitals. Since 2020, they've installed around 2000 critical care beds and modular operation theatres, mainly in Rajasthan. Their product range includes Electrosurgical Generators, LED Surgery Lights, ICU Ventilation Systems, and Anesthesia Workstations. With four warehouses in Ahmedabad and a team of 44 permanent employees (as of August 31, 2023), the company focuses on business operations, marketing, and accounting.
Strengths
- Fast-Growing Healthcare Infrastructure: The company is quickly expanding its presence by setting up healthcare facilities, boosting its market position.
- Expert in Healthcare Projects: With a solid track record of building ICUs, NICUs, PICUs, and Operation Theatres, the company proves its skill and reliability in handling complex projects.
- Strong Supplier Network: The company has strong partnerships with medical equipment suppliers, ensuring top-quality materials and on-time project delivery
Risk factors
- Dependence on Key Customers: If key customers stop buying or reduce their demand, it could badly affect the company's business and profits.
- Competitive Bidding and Uncertain Contracts: The company relies on bidding to win work orders, especially from government agencies with strict terms. Losing bids or not securing contracts can slow down business growth and impact profits.
- Healthcare Infrastructure Spending: The company's success largely depends on how much customers spend on healthcare infrastructure in India. If this spending goes down, it could hurt their business and earnings.
Promoters
Saurabh Kishorbhai Bhatt
Chetan Mohan Joshi
Registrar & documents
Lead manager
Hem Securities Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad-380015
+ 079-40068827
[email protected]Company website ↗Understanding APRAMEYA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.